ANXA2 and astrocytoma (excluding glioblastoma): The expression of ANXA2 and its pseudogenes were markedly higher in GBM samples than various low-grade gliomas (LGG, all P<0.001; Figure 2B) that refer to some diffuse gliomas (astrocytoma, oligoastrocytoma (OA) and oligodendroglioma).